Radiotoxicity on bone marrow after 89Sr therapy radiosensitized by nicotinamide and carbogen in mice.
OBJECTIVE
To investigate the radiotoxicity to bone marrow after 89Sr therapy radiosensitized by nicotinamide and carbogen.


METHODS
Chinese Kunming, NIH, BALB/c and F1 mice were divided into five groups: negative control (saline), positive control (89Sr), 89Sr+nicotinamide, 89Sr+carbogen and 89Sr+nicotinamide+carbogen. 89SrCl containing activities of 7400 kBq (200 microCi) in 200 microl of saline was administrated by injection into the tail vein. An equal volume of saline only was given to the negative control group. Chinese Kunming and NIH mice were killed on days 1, 2, 3, 4, 6, 8, 15, 20, 30, 60 and 90 after injection. BALB/c and F1 mice were killed on days 60 and 90. Femoral marrow reticulocytes were separated for assay of micronuclei.


RESULTS
The average frequency of the reticulocytes is shown in a dual-peak curve after injection. The first maximum frequency occurred between the second and the fourth days, and the second between the tenth and the 14th days. A significant statistical difference in frequency was found between the negative and the positive control groups (P<0.001, F=15.517), while no difference was found among the 89Sr+nicotinamide+carbogen, 89Sr, 89Sr+nicotinamide and 89Sr+carbogen groups (P>0.05, F=0.717) and among the NIH groups, 89Sr, 89Sr+nicotinamide, 89Sr+carbogen and 89Sr+nicotinamide+carbogen (P>0.05, F=1.734). There is also no significant difference in the frequency of reticulocytes between Chinese Kunming, NIH, BALB/c and F1 mice (P>0.05). Although the intervention of the radiosensitizer accelerated the occurrence of micronuclei in reticulocytes, there was no significant statistical difference between the group with radiosensitizer and the groups without it.


CONCLUSIONS
The administration of radiosensitizer did not aggravate the toxicity on bone marrow.
Zhang
Yingnan
Y
Department of Nuclear Medicine, Shengzhen People's Hospital, Jinan University, Shenzhen, Guangdong 518020, China. yingnazh@163.net
Zheng
Xiangpeng
X
Li
Tiyuan
T
Guo
Yiling
Y
Hang
Ruifang
R
Lin
Jihong
J
Gu
Weiwang
W
D000280:Administration, Inhalation; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects* / Q000293:injuries / Q000473:pathology / Q000528:radiation effects*; D002245:Carbon Dioxide / Q000008:administration & dosage*; D002875:Chromosomes / Q000187:drug effects / Q000528:radiation effects; D005260:Female; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D015162:Micronucleus Tests / Q000379:methods; D009536:Niacinamide / Q000008:administration & dosage*; D010100:Oxygen / Q000008:administration & dosage*; D011832:Radiation Injuries / Q000209:etiology / Q000473:pathology; D011836:Radiation Tolerance / Q000187:drug effects*; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage; D019275:Radiopharmaceuticals / Q000008:administration & dosage; D013326:Strontium Radioisotopes / Q000008:administration & dosage*
D011838:Radiation-Sensitizing Agents; D019275:Radiopharmaceuticals; D013326:Strontium Radioisotopes; D002245:Carbon Dioxide; D009536:Niacinamide; C011700:carbogen; D010100:Oxygen